Small molecule · developed by Novartis Pharmaceuticals
Phase 1Most advanced trial (none active)
1Registered trials
What is 4-Dimethylaminoazobenzene?
4-Dimethylaminoazobenzene (DAB) is a yellow crystalline azo compound that was used as a dye and pH indicator and is no longer produced in the United States. Exposure causes dermatitis, and it is reasonably anticipated to be a human carcinogen.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.